The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient/treatment characteristics and prognostic factors in small-cell bladder cancer (SCBC).
 
Vadim S Koshkin
No Relationships to Disclose
 
Hamid Emamekhoo
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Jesse McKenney
No Relationships to Disclose
 
Cristina Magi-Galluzzi
No Relationships to Disclose
 
Kim Schach
No Relationships to Disclose
 
Andrew J. Stephenson
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jorge A. Garcia
Honoraria - Astellas Pharma; Bayer; GlaxoSmithKline; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; GlaxoSmithKline; Lpath; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; GlaxoSmithKline; Pfizer; Sanofi
 
Petros Grivas
Consulting or Advisory Role - Bayer; Dendreon; Genentech
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst)